about
B cells in chronic graft-versus-host diseaseMesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal modelsContent Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.Ceramide synthesis regulates T cell activity and GVHD development.Transplantation of Donor-Origin Mouse Embryonic Stem Cell-Derived Thymic Epithelial Progenitors Prevents the Development of Chronic Graft-versus-Host Disease in Mice.An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.How we treat chronic graft-versus-host disease.Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.Aberrant B-cell homeostasis in chronic GVHDImpaired thymic expression of tissue-restricted antigens licenses the de novo generation of autoreactive CD4+ T cells in acute GVHD.Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantationEssential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in MiceDeficient regulatory B cells in human chronic graft-versus-host diseaseAdvances in understanding the pathogenesis of graft-versus-host disease.MicroRNA-17-92 controls T-cell responses in graft-versus-host disease and leukemia relapse in mice.Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the AEngraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management ApproachLate Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host DiseaseUnbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets.Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter surveyAntibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantationCirculating T follicular helper cells with increased function during chronic graft-versus-host diseasePreclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease.Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?IL-2, the next best thing in chronic GVHD therapy?Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease.Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells.Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.Biology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery.Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Old game, new players: Linking classical theories to new trends in transplant immunology.Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia
P2860
Q26861706-43DB7925-9CCC-4F1F-B3AF-3ADC775BA12BQ28085080-DE4DA02C-38AD-47F1-BCBC-3FC1BA5DB831Q30749782-AA0F1CDF-4961-4E83-8D8D-FCC96A3310ACQ33625948-09264542-AB79-4CCB-A3A7-AF4250CDFAA0Q33647028-14053570-467F-4FE0-8F19-048DFFD3E68CQ33703218-33597329-75B5-4091-B329-65DA4C996D60Q33722135-6E5F18C9-B767-4296-8556-C94B5DB089F9Q33798102-16E44F84-D319-43FF-B0CA-9954E29E9682Q35004923-7F1367E7-2F25-4DC4-8978-CAE7B6037481Q35022269-AC046179-0A6B-4B88-B066-5A06E1FD73E2Q35171251-01E92C30-5FC5-4C2F-A96F-686B9C9A3172Q35561300-6DA69DEF-DCF2-4655-8706-7F01666F9EF1Q35586614-70C8556C-3764-48A9-962B-A70EC7554BB3Q35738506-1BEC8966-3E0D-41C8-A131-93E31B29EB77Q35766798-F05F9D63-485D-4EF0-A6E4-E98486B5F4CFQ35799170-B2BC175C-2B88-43E9-BDA5-3246E2599DA3Q35971439-0E44DD9C-53C0-4F06-A1AA-08309E7B853BQ36051089-4300FDBE-3A87-45E6-B744-6F0ED744F7E0Q36056986-F67E6FB0-6C32-4C6E-9C91-529D03369307Q36091313-0CE43DB9-7166-4CDD-AD36-9383B7FBE430Q36125603-03CD342C-7454-4211-A73E-94F29956698FQ36264701-2D4AC277-76EC-4C9A-886B-62B0C5B96161Q36285222-F6C417ED-998D-4067-A52D-772DED7B1DA8Q36547819-6F19827D-BB5F-4983-868B-26A7594DCFD1Q36685390-92054430-EEED-4B88-9E7C-C693F318294CQ36862931-C1A8D1BF-81ED-47B1-B20C-F6CB177AA556Q36876981-4E8A441D-2C43-488B-AE57-A2D8A65D5047Q36891433-402FD3B1-E2E5-4E78-B126-914D670536B0Q36920466-0D03934A-443E-42DD-A4E6-52F58C6CD42AQ37035815-421DAA3B-0F56-46A9-A1C3-68EC090E500FQ37064425-164B3406-89BE-4A2E-A433-F583DA55371CQ37075990-F62F3620-76E9-43A2-ADE5-6717D6CE653FQ37076414-A430A704-393F-4108-AD48-6252B203E7A1Q37076418-B7599F9A-1E1E-446C-B177-359F4B6C6622Q37377103-1210FFAA-031D-42E9-8115-677419FA6FBBQ37488382-7E99EDC4-4595-4636-BFA5-D33A388E7322Q37522548-D01F7377-99F3-41E2-8693-874E4975A5C7Q37618811-EA0900B7-E46F-407B-8E06-BBE5C23BE156Q37662989-EAB75DBB-62AA-4519-B841-872E5F23F1E4Q37702242-A1E1782C-CEF2-4DCC-A30B-BFC534924B7B
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Current issues in chronic graft-versus-host disease.
@ast
Current issues in chronic graft-versus-host disease.
@en
type
label
Current issues in chronic graft-versus-host disease.
@ast
Current issues in chronic graft-versus-host disease.
@en
prefLabel
Current issues in chronic graft-versus-host disease.
@ast
Current issues in chronic graft-versus-host disease.
@en
P2860
P1433
P1476
Current issues in chronic graft-versus-host disease.
@en
P2093
Jerome Ritz
P2860
P304
P356
10.1182/BLOOD-2014-01-514752
P407
P50
P577
2014-06-09T00:00:00Z